Cancer drug trial at Suffolk hospital

DOCTORS at a Suffolk hospital are looking for patients to take part in a new lung cancer trial today.

DOCTORS at a Suffolk hospital are looking for patients to take part in a new lung cancer trial today.

Staff at West Suffolk Hospital in Bury St Edmunds are investigating how a blood thinning drug might help prevent blood clots in lung cancer patients.

The Cancer Research UK funded trial, named FRAGMATIC, is investigating whether a drug called Dalteparin can treat clots and whether the drug may also improve the survival of lung cancer patients.

People with lung cancer are at an increased risk of dangerous and potentially fatal blood clots in their veins because of chemotherapy, surgery, inactivity or the lung cancer itself.

Throughout the UK about 2,200 patients are wanted to take part in the trial.

Dr Hugo Ford, who is working on the trial at West Suffolk Hospital, said: “We are pleased to be helping with this major UK-wide trial by recruiting people across Suffolk.

Most Read

“We are all working hard to find better and more effective ways to treat this difficult illness.”

For more information on the trial visit www.cancerhelp.org.uk or call the Cancer Research UK cancer information nurses on 0808 8004040.